Antiangiogenic-Associated Hypertension
1 clinical trials · Condition
◉ Watch Antiangiogenic-Associated Hypertension
| Record | Firm | Date |
|---|---|---|
| Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension (NCT06515678) | Groupe Hospitalier Pitie-Salpetriere | 2024-05-20 |
Track Antiangiogenic-Associated Hypertension automatically
Every clearance here is in the API, with alerts when new ones post.